<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We examined whether a nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> scavenger, 2-(4-carboxyphenyl)-4,4,5,5-tetramethyl-<z:chebi fb="1" ids="53094">imidazoline</z:chebi>-L: -oxyl-3-<z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (carboxy-PTIO), could offer neuroprotective actions and improve cerebral energy metabolism in a model of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Sixty C57BL/10J mice were given either carboxy-PTIO (0.3-1.2 mg/kg) or vehicle intraperitoneally, 0.5 h after permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, to evaluate the dose-response effects </plain></SENT>
<SENT sid="2" pm="."><plain>An additional 70 animals received carboxy-PTIO (0.6 mg/kg) or vehicle, 2-6 h post-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, for establishing the therapeutic window </plain></SENT>
<SENT sid="3" pm="."><plain>Subgroups of animals, treated with carboxy-PTIO (0.6 mg/kg) or vehicle, were used for measuring cerebral bioenergetic metabolites (ATP, <z:chebi fb="13" ids="16761">ADP</z:chebi>, <z:chebi fb="47" ids="16027,28971">AMP</z:chebi>, <z:chebi fb="3" ids="16335">adenosine</z:chebi>) </plain></SENT>
<SENT sid="4" pm="."><plain>Mice treated with carboxy-PTIO (0.6 mg/kg) had dose-specifically reduced <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e>, significantly by 27-30% (P &lt; 0.05), even when therapy was delayed up to 4 h after the ischemic insult (P &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>Four hour post-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, ATP depleted in the ischemic hemisphere (P &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>Administration with carboxy-PTIO not only improved the recovery of ATP in the ischemic hemisphere (P &lt; 0.05), but also enhanced <z:chebi fb="3" ids="16335">adenosine</z:chebi> content across the ischemic and non-ischemic hemispheres (P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>The neuroprotection of carboxy-PTIO may be partly attributed to the beneficial effects of improving cerebral energy metabolism </plain></SENT>
</text></document>